Literature DB >> 2112185

In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.

E J Read1, A M Keenan, C S Carter, P S Yolles, R J Davey.   

Abstract

The in vivo traffic patterns of autologous lymphocytes were studied in five normal human volunteers using lymphocytes obtained by automated apheresis, separated on Ficoll-Hypaque gradients, and labeled ex vivo with 111In-oxine. Final lymphocyte infusions contained 1.8-3.1 X 10(9) cells and 270-390 microCi (9.99-14.43 MBq) 111In, or 11-17 microCi (0.41-0.63 MBq) per 10(8) lymphocytes. Gamma imaging showed transient lung uptake and significant retention of radioactivity in the liver and spleen. Progressive uptake of activity in normal, nonpalpable axillary and inguinal lymph nodes was seen from 24 to 96 hr. Accumulation of radioactivity also was demonstrated at the forearm skin test site, as well as in its associated epitrochlear and axillary lymph nodes, in a subject who had been tested for delayed hypersensitivity with tetanus toxoid. Indium-111-oxine labeled human lymphocytes may provide a useful tool for future studies of normal and abnormal lymphocyte traffic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112185

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma.

Authors:  Birgit Meller; Christoph Frohn; Jörg-Matthias Brand; Isabel Lauer; Lutz F Schelper; Katharina von Hof; Holger Kirchner; Eckart Richter; Manfred Baehre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

2.  Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers.

Authors:  Chunsheng Liu; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther       Date:  2010-03-16       Impact factor: 11.454

3.  Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia.

Authors:  Karen Thudium Mueller; Shannon L Maude; David L Porter; Noelle Frey; Patricia Wood; Xia Han; Edward Waldron; Abhijit Chakraborty; Rakesh Awasthi; Bruce L Levine; J Joseph Melenhorst; Stephan A Grupp; Carl H June; Simon F Lacey
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

4.  Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.

Authors:  Emily K Mader; Yoshihiro Maeyama; Yi Lin; Greg W Butler; Holly M Russell; Evanthia Galanis; Stephen J Russell; Allan B Dietz; Kah-Whye Peng
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

5.  Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.

Authors:  Hooi-Tin Ong; Mark J Federspiel; Chang M Guo; London Lucien Ooi; Stephen J Russell; Kah-Whye Peng; Kam M Hui
Journal:  J Hepatol       Date:  2013-07-16       Impact factor: 25.083

6.  Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo.

Authors:  J Kelsen; J Agnholt; L Falborg; J T Nielsen; J L Rømer; H J Hoffmann; J F Dahlerup
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

7.  Mononucleated Blood Cell Populations Display Different Abilities To Transmit Prion Disease by the Transfusion Route.

Authors:  Jean-Yves Douet; Caroline Lacroux; Claire Litaise; Séverine Lugan; Fabien Corbière; Mark Arnold; Hugh Simmons; Naima Aron; Pierrette Costes; Cécile Tillier; Hervé Cassard; Olivier Andréoletti
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

Review 8.  In vivo imaging of therapy-induced anti-cancer immune responses in humans.

Authors:  Erik H J G Aarntzen; Mangala Srinivas; Caius G Radu; Cornelis J A Punt; Otto C Boerman; Carl G Figdor; Wim J G Oyen; I Jolanda M de Vries
Journal:  Cell Mol Life Sci       Date:  2012-10-05       Impact factor: 9.261

9.  Trafficking of CAR-engineered human T cells following regional or systemic adoptive transfer in SCID beige mice.

Authors:  Ana Caterina Parente-Pereira; Jerome Burnet; David Ellison; Julie Foster; David Marc Davies; Sjoukje van der Stegen; Sophie Burbridge; Laura Chiapero-Stanke; Scott Wilkie; Stephen Mather; John Maher
Journal:  J Clin Immunol       Date:  2011-04-20       Impact factor: 8.317

10.  Evaluating the effect of ultrasmall superparamagnetic iron oxide nanoparticles for a long-term magnetic cell labeling.

Authors:  Saeed Shanehsazzadeh; Mohammad Ali Oghabian; Barry J Allen; Massoud Amanlou; Afshin Masoudi; Fariba Johari Daha
Journal:  J Med Phys       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.